Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 4262536, 9 pages
https://doi.org/10.1155/2017/4262536
Research Article

Liver Biomarkers and Lipid Profiles in Mexican and Mexican-American 10- to 14-Year-Old Adolescents at Risk for Type 2 Diabetes

1Facultad de Medicina, Universidad Autónoma del Estado de México, Paseo Tollocan Esq. Jesús Carranza. Col. Moderna de la Cruz, 50180 Toluca, MEX, Mexico
2Department of Family Medicine, Texas Prevention Institute, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107, USA
3Department of Pediatrics, Texas Prevention Institute, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107, USA

Correspondence should be addressed to Roxana Valdés-Ramos; xm.xemeau@rsedlavr

Received 21 March 2017; Accepted 3 July 2017; Published 26 July 2017

Academic Editor: Tarunveer Singh Ahluwalia

Copyright © 2017 Ana Cecilia Fernández-Gaxiola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association, “Standards of medical Care in Diabetes 2012,” Diabetes Care, vol. 2012, Supplement 1, no. 35, pp. s11–s63.
  2. M. Stumvoll, B. J. Goldstein, and T. W. Haeften, “Type 2 diabetes: principles of pathogenesis and therapy,” Lancet, vol. 365, pp. 1333–1346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Kaprio, J. Tuomilehto, M. Koskenvuo et al., “Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland,” Diabetologia, vol. 35, pp. 1060–1067, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. A. L. Williams, S. B. Jacobs, H. Moreno-Macías et al., “SIGMA type 2 diabetes consortium. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico,” Nature, vol. 506, no. 7486, pp. 97–101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Gutiérrez-Vidal, A. Rodríguez-Trejo, S. Canizales-Quinteros et al., “LOC387761 polymorphism is associated with type 2 diabetes in the Mexican population,” Genetic Testing and Molecular Biomarkers, vol. 15, no. 1–2, pp. 79–83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. G. Alberti, P. Zimmet, and J. Shaw, “International diabetes federation: a consensus on type 2 diabetes prevention,” Diabetic Medicine, vol. 24, pp. 451–463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Liu, S. Que, J. Xu, and T. Peng, “Alanine aminotransferase-old biomarker and new concept: a review,” International Journal of Medical Sciences, vol. 11, no. 9, pp. 925–935, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Sookian and C. J. Pirola, “Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine,” World Journal of Gastroenterology, vol. 21, no. 3, pp. 711–725, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. R. K. Schindhelm, M. Diamant, J. M. Dekker, M. E. Tushuizen, T. Teerlink, and R. J. Heine, “Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease,” Diabetes/Metabolism Research and Reviews, vol. 22, no. 6, pp. 437–443, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. E. Yun, S. Y. Kim, H. C. Kang, S. J. Lee, H. Kimm, and S. H. Jee, “Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance,” Circulation Journal, vol. 75, no. 4, pp. 964–969, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. H. Lee, M. H. Ha, J. H. Kim et al., “Gamma-glutamyl transferase and diabetes - a 4-year follow-up study,” Diabetologia, vol. 46, pp. 359–364, 2003. View at Publisher · View at Google Scholar
  12. D. H. Lee, D. R. Jacobs, M. Gross et al., “Gamma glutamyltransferase is a predictor of incident diabetes and hypertension: the CARDIA study,” Clinical Chemistry, vol. 49, pp. 1358–1366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. D. H. Lee, K. Silventoinen, D. R. Jacobs Jr, P. Jousilahti, and J. Tuomileto, “Gamma-glutamyl transferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, pp. 5410–5414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Andre, B. Balkau, C. Born, M. A. Charles, and E. Eschwege, “D.E.S.I.R. Study group. Three-year increase of gamma-glutamyl transferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. Cohort,” Diabetologia, vol. 49, pp. 2599–2603, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. K. velu V, B. Jyothirmayi, and J. S. Kumar, “Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 5, no. 3, pp. 143–147, 2011. View at Google Scholar
  16. J. West, J. Brousil, A. Gazis, L. Jackson, P. Mansell, and A. Bennett, “Elevated serum alanine aminotransferasein patients with type 1 or type 2 diabetes mellitus,” QJM, vol. 99, no. 12, pp. 871–876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. G. Wannamethee, A. G. Shaper, L. Lennon, and P. H. Whincup, “Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men,” Diabetes Care, vol. 28, pp. 2913–2918, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Nakanishi, K. Suzuki, and K. Tatara, “Serum-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men,” Diabetes Care, vol. 27, pp. 1427–1432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. J. Hanley, K. Williams, A. Festa et al., “The insulin resistance atherosclerosis study. Elevations in markers of liver injury and risk of type 2 diabetes: the Insulin Resistance Atherosclerosis Study,” Diabetes, vol. 53, pp. 2623–2632, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Fraser, R. Harris, N. Sattar, S. Ebrahim, S. G. Davey, and D. A. Lawlor, “Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women’s Heart and Health Study and meta-analysis,” Diabetes Care, vol. 32, pp. 741–750, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Vozarova, N. Stefan, R. S. Lindsay et al., “High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes,” Diabetes, vol. 51, pp. 1889–1895, 2002. View at Publisher · View at Google Scholar
  22. T. Bulum, B. Kolarić, M. Duvnjak, and L. Duvnjak, “Alkaline phosphatase is independently associated with renal function in normoalbuminuric type 1 diabetic patients,” Renal Failure, vol. 36, no. 3, pp. 372–377, 2014. View at Google Scholar
  23. G. Sesti, T. V. Fiorentino, M. L. Hribal, A. Sciacqua, and F. Perticone, “Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers,” Nutrition, Metabolism, and Cardiovascular Diseases, vol. 23, no. 12, pp. 1182–1187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Pados and M. Au-dikovszky, “Lipid-lowering therapy in patients with type-2 diabetes mellitus,” Orvosi Hetilap, vol. 144, no. 12, pp. 557–561, 2013. View at Google Scholar
  25. C. Munguía-Miranda, R. G. Sánchez-Barrera, D. Hernández-Saavedra, and M. Cruz-López, “Prevalencia de dislipidemias en una población de sujetos aparentemente sanos y su relación con la resistencia a la insulina,” Salud Pública de México, vol. 50, pp. 375–382, 2008. View at Publisher · View at Google Scholar
  26. M. Hernández-Avila and J. P. Gutiérrez, in Diabetes mellitus: la urgencia de reforzar la respuesta en políticas públicas para su prevención y control. Encuesta Nacional de Salud y Nutrición 2012 Evidencia para la política pública en Salud, Instituto Nacional de Salud Pública (National Institute of Public Health), Cuernavaca, Mexico, 2013.
  27. M. S. Schwartz and A. Chadha, “Type 2 diabetes mellitus in childhood: obesity and insulin resistance,” The Journal of the American Osteopathic Association, vol. 108, no. 9, pp. 518–524, 2008. View at Google Scholar
  28. C. C. Cowie, K. F. Rust, D. D. Byrd-Holt et al., “Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006,” Diabetes Care, vol. 33, no. 3, pp. 562–568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. E. Hale and G. Rupert, “The changing spectrum of diabetes in Mexican American youth,” Reviews in Endocrine & Metabolic Disorders, vol. 7, no. 3, pp. 163–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Hernández-Avila, J. P. Gutiérrez, and N. Reynoso-Roverón, “Diabetes mellitus en México: el estado de la epidemia,” Salud Pública de México, vol. 55, Supplement 2, pp. S129–S136, 2013. View at Google Scholar
  31. American Diabetes Association, “Standards of medical Care in Diabetes 2014,” Diabetes Care, vol. 37, Supplement 1, pp. S14–S80, 2014. View at Google Scholar
  32. S. Peterson, S. Sheffer, S. Long-Roth, P. A. Bennett, and L. Lloyd, “Noninvasive screening for risk factors of type 2 diabetes in young, rural Caucasian Children,” Journal of School Nursing, vol. 26, no. 4, pp. 301–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. National High Blood Pressure Education Program Working Group on high blood pressure in children and adolescents, “The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents,” Pediatrics, vol. 114, Supplement 2, pp. 555–576, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. World Health Organization, “Physical status: the use and interpretation of anthropometry,” Tech. Rep., WHO Technical Report Series 845, WHO, Geneve, 1995. View at Google Scholar
  35. Centers for Disease Control and Prevention, “2000 CDC growth charts. Department of Health and Human Services,” Vital and Health Statistics Series, vol. 11, no. 246, 2000. View at Google Scholar
  36. C. D. Fryar, Q. Gu, and C. L. Ogden, “Anthropometric reference data for children and adults: United States, 2007–2010. National Center for Health Statistics,” Vital and Health Statistics, vol. 11, no. 252, pp. 1–48, 2012. View at Google Scholar
  37. J. P. Gutierrez, J. Rivera-Dommarco, T. Shamah-Levy et al., “Encuesta Nacional de Salud y NutriciónResultados Nacionales,” in Cuernavaca, vol. 1, no. 1.48, Instituto Nacional de Salud Pública (MX), México, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Sattar, O. Scherbakova, I. Ford et al., “Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study,” Diabetes, vol. 53, no. 11, pp. 2855–2860, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. M. I. Goran and B. A. Gower, “Longitudinal study on pubertal insulin resistance,” Diabetes, vol. 50, pp. 2444–2450, 2001. View at Publisher · View at Google Scholar
  40. M. Nannipieri, C. Gonzales, S. Baldi et al., “Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study,” Diabetes Care, vol. 28, no. 7, pp. 1757–1762, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Tobiume, S. Kanzaki, S. Hida et al., “Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy,” The Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 7, pp. 2056–2061, 1997. View at Publisher · View at Google Scholar
  42. D. Wei, T. Chen, Y. Gao, and H. Tian, “Serum gamma-glutamyltransferase and ferritin are related to insulin resistance: a population-based study,” Clinical Laboratory, vol. 61, no. 9, pp. 1157–1161, 2015. View at Publisher · View at Google Scholar · View at Scopus